Miacalcic is used to treat Paget disease, contributes to the treatment of osteoporosis and helps reduce excess calcium levels in the body that may lead to bone cancer. It is also used to treat bone loss and increased susceptibility to fracture.
Miacalcic contains the hormone calcitonin, which is a laboratory-made hormone that mimics the natural hormone produced by the thyroid gland and plays an important role in controlling calcium levels in the body, as it regulates absorption and excretion in bone tissue.
It also works to inhibit the activity of bone-destroying cells and reduces the deterioration of bone tissue.